ENTITY
BioNTech

BioNTech (BNTX US)

49
Analysis
Health Care • Germany
BioNTech SE provides biotechnological solutions. The Company develops various types of treatments for cancer patients' tumors. BioNTech serves customers worldwide.
more
•23 Jun 2025 12:48•Syndicated

Chinese Biotech Innovators Push Overseas as Sector Faces Reckoning

After years of falling valuations and stalled IPO activity, China’s innovative drug industry is showing early signs of a comeback. A spate of...

Logo
345 Views
Share
•23 Dec 2022 10:46•Syndicated

CX Daily: Why China’s Social Relief Efforts Have Fallen Short

Why China’s social relief efforts have fallen short. Germans will soon be able to access BioNTech shot on mainland, ambassador says. China,...

Logo
757 Views
Share
•21 Dec 2022 10:21•Syndicated

CX Daily: What’s in Store for China GDP, Fiscal Policy in 2023

What’s in store for China GDP, fiscal policy in 2023. Hong Kong approval expands mainlanders’ access to mRNA Covid shots. Chinese exporters lose...

Logo
609 Views
Share
•15 Dec 2022 14:11•Syndicated

CX Daily: Chinese Mainlanders Rush to Macao for MRNA Vaccinations

Chinese mainlanders rush to Macao for mRNA vaccinations. Hong Kong readies crypto futures ETFs for retail investors. China calls India border...

Logo
611 Views
Share
•04 Dec 2022 10:26•Syndicated

Weekly Stock Bullfinder - Week of 12/5

As investors we are faced with a deluge of noisy breaking news, business media talking heads, and what has felt like non-stop Fed speakers offering...

Share
x